For CATEGORY A. a) In case of sales or other commercial use of a LICENSED PRODUCT by a sublicensee, […***…]% on NET SALES invoiced by sublicensee; and b) In case of sales or other commercial use of a LICENSED SERVICE by a sublicensee, […***…]% on NET SALES invoiced by sublicensee; and c) […***…]% of other payments (execution fee, milestones, payments in consideration of the issuance of equity, etc., but excluding royalty payments, loans, profit sharing payments (so long as LICENSEE pays the NET SALES royalties in Section 4.4 on LICENSED PRODUCT and/or LICENSED SERVICE NET SALES), cost-covering supply reimbursement and cost-covering reimbursements for research or development activities) received by LICENSEE from a sublicensee as a quid pro quo for the grant of the sublicense (hereinafter “Other Payments”)
Appears in 4 contracts
Samples: License Agreement (Poseida Therapeutics, Inc.), License Agreement (Poseida Therapeutics, Inc.), License Agreement (Poseida Therapeutics, Inc.)
For CATEGORY A. (a) In case of sales or other commercial use of a LICENSED PRODUCT by a sublicensee, […***…]% on NET SALES invoiced by sublicensee; and
(b) In case of sales or other commercial use of a LICENSED SERVICE by a sublicensee, […***…]% on NET SALES invoiced by sublicensee; and
(c) […***…]% of other payments (execution fee, milestones, payments in consideration of the issuance of equity, etc., but excluding royalty payments, loans, profit sharing payments (so long as LICENSEE pays the NET SALES royalties in Section 4.4 on LICENSED PRODUCT and/or LICENSED SERVICE NET SALES), cost-covering supply reimbursement and cost-covering reimbursements for research or development activities) received by LICENSEE from a sublicensee as a quid pro quo for the grant of the sublicense (hereinafter “Other Payments”).
Appears in 1 contract
